SANDOZ FARMACEUTICA, SA secures contract for Pharmaceutical Products - Supply of original and biosimilar biological medicines based on the active ingredients Adalimumab, Trastuzumab, ETERECPT, Rituximab, Inflicimab and Bevacizumab for the Miguel Servet University Hospital in Zaragoza

Spain, April 8 -- Spain based SANDOZ FARMACEUTICA, SA has secured contract from Gerencia Sector Sanitario de Zaragoza 2 for Pharmaceutical Products - Supply of original and biosimilar biological medicines based on the active ingredients Adalimumab, Trastuzumab, ETERECPT, Rituximab, Inflicimab and Bevacizumab for the Miguel Servet University Hospital in Zaragoza. The value of the contract is worth 73949050 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....